This article was originally published in The Tan Sheet
Nepera subsidiary signs letter of intent to form a joint venture to manufacture and market niacin and niacinamide in China with two partners -- Beijing No. 2 Pharmaceutical Factory, which currently makes these products, and Nichimen, which the firm describes as "one of the largest non-Chinese trading companies" in China
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC